Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Alzheimers Dement. 2015 Jan 12;11(10):1202–1211. doi: 10.1016/j.jalz.2014.11.003

Table 1.

Characteristics of sample and differences between statin exposed* vs unexposed.

All Statin
exposed
Statin
unexposed
P value
Number 295 109 186
Age (mean±SD), years 80.1±2.8 79.8 80.3 0.300
Women, N (%) 168 (57%) 55 (51%) 113 (61%) 0.089
Black, N (%) 118 (40%) 75 (40%) 43 (40%) 0.902
High school Education, N (%) 256 (87%) 97 (90%) 159 (86%) 0.367
Hypertension, N (%) 174 (60%) 77 (71%) 97 (52%) 0.002
Diabetes mellitus, N (%) 48 (16%) 25 (23%) 23 (12%) 0.022
Coronary heart disease, N (%) 64 (22%) 37 (34%) 27 (15%) <0.001
Stroke, N (%) 23 (7%) 9 (8%) 14 (8%) 0.825
Alcohol consumption, N (%) 172 (58%) 66 (61%) 106 (57%) 0.624
Peripheral arterial disease, N (%) 10 (3%) 7 (6%) 3 (2%) 0.042
APOE4-positive status N (%) 73 (26.1%) 30 (28.0%) 43 (24.9%) 0.5557
Serum LDL levels (mg/dl) 115.1±31.7 96.0±24.8 125.9±30.2 <0.0001
3MS 92.77±6.17 93.1 92.3 0.30
*

Statin exposure defined as those identified as using a statin based on codes belonging to statin class of drugs.

3MS: Modified Mini-mental Status Examination

APOE4 positive stats: presence of apolipoprotein-epsilon 4 allele

LDL: low-density lipoprotein